Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemohormonal therapy before robot-assisted radical prostatectomy for high-risk prostate cancer
jRCTs061180057Recruiting
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of bicalutamide, docetaxel and prednisolone in prostate cancer (PCa). Primary endpoints: Pathological assessment of resected prostate tissue and Postoperative PSA recurrence-free rate. Started Dec 2016; status: recruiting.
02
Drugs
bicalutamidedocetaxelprednisolone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCTs061180057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061180057.